[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351556-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-351556-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","subsequent-primary-cancer-incidence-among-cancer-survivors-in-the-united-states-1975-2019-an-age-period-cohort-analysis","Subsequent primary cancer incidence among cancer survivors in the United States, 1975-2019 - An age-period-cohort analysis","","Growing numbers of cancer survivors face heightened risk of subsequent primary cancers (SPCs), while temporal variation in SPC incidence remains insufficiently characterized. Using US population-based SEER 8 data, a retrospective cohort study followed 3.36 million individuals diagnosed with a first primary cancer from 1975 to 2019 through 2022. Age-period-cohort analyses quantified longitudinal age curves, cohort/period rate ratios, and annual percent changes, stratified by sex and major index cancer sites. SPC incidence rose with age, cohort risk peaked in 1935–1945 and declined thereafter, and period patterns showed overall declines but increasing risk for older diagnosis ages and select sites.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/subsequent-primary-cancer-incidence-among-cancer-survivors-in-the-united-states-1975-2019-an-age-period-cohort-analysis/351556/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/subsequent-primary-cancer-incidence-among-cancer-survivors-in-the-united-states-1975-2019-an-age-period-cohort-analysis/351556.png","ImageObject",300,407,{"name":42,"@type":43},"Bintang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is the main goal of the study on subsequent primary cancer (SPC) incidence?","Question",{"text":62,"@type":63},"To characterize age-, period-, and cohort-specific patterns in SPC incidence among US cancer survivors using population-based data.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How was the cohort constructed and what data source was used?",{"text":67,"@type":63},"A retrospective cohort study used SEER 8 registries, identifying 3.36 million people diagnosed with a first primary cancer between 1975 and 2019, and followed survivors through 2022.",{"name":69,"@type":60,"acceptedAnswer":70},"What trends in SPC incidence were observed by age and sex?",{"text":71,"@type":63},"SPC incidence increased with age at index diagnosis, with steeper rises among males; females rose from 915 to 1,980 per 100,000 person-years across the cited age groups, while males rose from 1,228 to 2,945.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},351556,1790561696,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","OPEN ACCESS  \nCitation: Cheng HG, Aduse-Poku L, McGill C, Palesh O, Hong S (2026) Subsequent primary cancer incidence among cancer survivors in the United States, 1975–2019: An age–period– cohort analysis. PLoS Med 23(4): e1005034 .  \n[https://doi.org/10.1371/journal.pmed.1005034](https://doi.org/10.1371/journal.pmed.1005034)[ ](https://doi.org/10.1371/journal.pmed.1005034)[Academic Editor:](Academic Editor: Mahdi Sheikh)[ Mahdi Sheikh](Academic Editor: Mahdi Sheikh), International Agency for Research on Cancer, FRANCE Received: October 1, 2025  \nAccepted: March 19, 2026  \nPublished: April 28, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pmed.1005034  \nCopyright: © 2026 Cheng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  \nRESEARCH ARTICLE  \nSubsequent primary cancer incidence among cancer survivors in the United States, 1975–2019:  \nAn age–period–cohort analysis  \nHui G. Cheng1*, Livingstone Aduse-Poku1, Chelsey McGill1,2, Oxana Palesh1,2‡, Susan Hong1,3‡  \n1 Cancer Prevention and Survivorship Outcomes Research Lab, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia, United States of America, 2 Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America, 3 Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America  \n‡ These authors are co-senior authors on this work.  \n* [hcheng3@vcu.edu](hcheng3@vcu.edu)  \nAbstract  \nBackground  \nThe growing population of cancer survivors faces elevated risks of subsequent primary cancers (SPCs), yet temporal patterns in SPC incidence remain poorly understood. This study aims to characterize age- , period- , and cohort-specific patterns in SPC incidence among US cancer survivors using population-based data.  \nMethods and findings  \nWe conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) 8 registries, identifying 3.36 million individuals diagnosed with a first primary cancer between 1975 and 2019. Survivors were followed through 2022 to estimate the incidence of SPCs. We used age–period–cohort analysis to estimate longitudinal age curves, cohort and period rate ratios, and annual percent changes in SPC incidence. Analyses were stratified by sex and the five most common index cancer sites. During 29.5 million person-years of follow-up, 510,340 SPCs were observed. SPC incidence increased with age at index cancer diagnosis, rising among females from 915 per 100,000 person-years at ages 35–39 years to 1,980 per 100,000 at ages 75–79 years, and among males from 1,228 per 100,000 to 2,945 per 100,000 across the same age groups, demonstrating steeper rises in men. Cohort-specific SPC risk peaked in the 1935–1945 birth cohorts and declined in later cohorts, except among female survivors of lung cancer and male survivors of bladder cancer, where risks continued to rise. Period patterns showed overall declines in SPC incidence, particularly among survivors diagnosed at a younger age, but increasing risks among survivors diagnosed at an older age and survivors of specific index cancer sites. Notably,  \nPLOS Medicine | [https://doi.org/10.1371/journal.pmed.1005034](https://doi.org/10.1371/journal.pmed.1005034) April 28, 2026 1 / 15  \nand reproduction in any medium, provided the original author and source are credited.  \nData availability statement: The data underlying this article (SEER 8 registries, 2024 submission) are a","cbCaic5LaHyapzmJ","https://ap.wps.com/l/cbCaic5LaHyapzmJ","pdf",1758225,15,"English","# Abstract\n## Background\n## Methods and findings\n## Conclusions","[{\"question\":\"What is the main goal of the study on subsequent primary cancer (SPC) incidence?\",\"answer\":\"To characterize age-, period-, and cohort-specific patterns in SPC incidence among US cancer survivors using population-based data.\"},{\"question\":\"How was the cohort constructed and what data source was used?\",\"answer\":\"A retrospective cohort study used SEER 8 registries, identifying 3.36 million people diagnosed with a first primary cancer between 1975 and 2019, and followed survivors through 2022.\"},{\"question\":\"What trends in SPC incidence were observed by age and sex?\",\"answer\":\"SPC incidence increased with age at index diagnosis, with steeper rises among males; females rose from 915 to 1,980 per 100,000 person-years across the cited age groups, while males rose from 1,228 to 2,945.\"}]","Subsequent primary cancer incidence among cancer survivors in the United States, 1975-2019 - An age-period-cohort analysis | PDF",1790094709,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e8627adb4c0a40ff7403e6512b03e21.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ad080c0dac71e89129afdaaae55da92.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0cadf782f25e978a14d5dcf2995c0357.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/505f4dd5ad0bf1ee78123b5d6d1dd4a4.webp",980,1268]